NCT02907203View on ClinicalTrials.gov

Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)

CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

March 22, 2022

Study Completion Date

March 22, 2022

Conditions
PAD
Interventions
DEVICE

Drug Coated Balloon

Prospective, multi-center, single-arm study characterizing outcomes in subjects with Peripheral Artery Disease (PAD) lesions treated with percutaneous transluminal angioplasty (PTA) using the GORE® DCB Catheter.

Trial Locations (1)

Unknown

Universitats - Herzzentrum Freiburg, Bad Krozingen

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT02907203 - Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter) | Biotech Hunter | Biotech Hunter